Free Research Reports on CLF, IMGN, SVNT and TSYS Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT
NEW YORK, NY -- (Marketwire) -- 11/05/12 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.
Cliffs Natural Resources Inc. (NYSE: CLF) shares have fallen sharply this past week after reporting third quarter profit declined 86 percent to $85.1 million. For 2012, the company has reduced its U.S. iron ore sales volume expectation to 22 million tons from its previous expectation of 23 million tons.
ImmunoGen, Inc. (NASDAQ: IMGN) shares declined 16 percent after reporting losses widened to $25.2 million in the fiscal first quarter, from to a net loss of $19.5 million in the year-ago quarter. The company expects to file for marketing approval of its cancer drug T-DM1 in 2015.
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) earlier this month received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending approval of a marketing authorization in the European Union for KRYSTEXXA. The company will release third quarter results on November 8, 2012.
TeleCommunication Systems, Inc. (NASDAQ: TSYS) shares of the wireless communications company soared 17 percent Friday after reporting third quarter revenue increased 24 percent to a record of $140.1 million.
Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com, has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, have a financial relationship with any company whose stock is mentioned in this release.